Hypertrophic cardiomyopathy: Difference between revisions

Jump to navigation Jump to search
Line 42: Line 42:
*[[Hypertrophic cardiomyopathy treatment strategy|Treatment Strategy]]
*[[Hypertrophic cardiomyopathy treatment strategy|Treatment Strategy]]


*'''Medical therapy:''' [[Hypertrophic cardiomyopathy medical treatment#Simple Supportive Measures|Supportive Therapy]] | [[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]] | [[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients|Pharmacotherapy Guidelines]]  
*'''Medical therapy:''' [[Hypertrophic cardiomyopathy medical treatment#Simple Supportive Measures|Supportive Therapy]] | [[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]]  


*'''Invasive therapies:''' [[Hypertrophic cardiomyopathy alcohol septal ablation|Alcohol Septal Ablation]] | [[Hypertrophic cardiomyopathy septal myectomy|Septal Myectomy]] | [[Hypertrophic cardiomyopathy ventricular pacing|Ventricular Pacing]] | [[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement|Automatic Implantable Cardiac Defibrillator (AICD) Placement]] | [[Hypertrophic cardiomyopathy invasive therapy guidelines|Septal Reduction Therapy Guidelines]]  
*'''Invasive therapies:''' [[Hypertrophic cardiomyopathy alcohol septal ablation|Alcohol Septal Ablation]] | [[Hypertrophic cardiomyopathy septal myectomy|Septal Myectomy]] | [[Hypertrophic cardiomyopathy ventricular pacing|Ventricular Pacing]] | [[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement|Automatic Implantable Cardiac Defibrillator (AICD) Placement]] | [[Hypertrophic cardiomyopathy invasive therapy guidelines|Septal Reduction Therapy Guidelines]]  

Revision as of 02:59, 3 October 2012

For patient information click here

Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10 I42.1-I42.2
ICD-9 425.4
DiseasesDB 6373
MeSH D002312

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy

CDC on Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy in the news

Blogs on Hypertrophic cardiomyopathy

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent)

Overview

Classification

Pathophysiology

Genetics | Histopathologic Abnormalities | Anatomic Abnormalities | Outflow Obstruction | Ischemia | Arrhythmogenesis

Epidemiology and Demographcis

Screening

Differential Diagnosis

Natural History, Prognosis and Sudden Cardiac Death Risk

Diagnosis

History and Symptoms | Physical examination | Electrocardiogram | Echocardiography | Cardiac MRI | Cardiac CT | Positron Emission Tomography | Pathological Findings

Treatment

Special Patient Populations

Hypotension/Cardiovascular collapse | Pregnancy

2011 ACCF/AHA Guideline Recommendations

Diagnostic testing:

Electrocardiogram | Echocardiography | Stress Echocardiography | Stress Testing | Cardiac Magnetic Resonance | Cardiac CT | Positron Emission Tomography

Management:

Resources


Template:WikiDoc Sources